Renegade Neurologist

I am greatly honored to be invited to address the First International Congress on Alzheimer’s in Monaco under the Patronage of HRH Prince Albert II of Monaco.

Here is a letter from the president of the organization:

Despite the Billions of dollars spent annually to cure this disease,
Alzheimer’s claims over 1 in 10 people over the age of 65 and represents
a growing threat in the backdrop of an aging population. In fact, it is
expected to claim over half of the people over 85 in coming years.
Coincidentally, the past twenty years have seen substantial advances
in the Neurosciences and allied fields. These major contributions, from
the discovery of human stem cells in areas affected by Alzheimer’s to
the sequencing of the Human Genome, have given rise to new tools,
which are ripe for applications to the fi eld Alzheimer’s. It is high time
to introduce researchers responsible for these fi ndings to the Alzheimer’s community. In this
spirit, we have convened some of the world’s most daring and innovative researchers to share
their insights in the form of an international summit with Alzheimer’s as a leitmotiv, held in the
Principality of Monaco in February 2010.
I am grateful to Prince Albert II of Monaco, Madame Catherine Pastor of AMPA and First Lady
Bernadette Chirac for the invitation to create this event and for recognizing the need to develop
completely novel strategies against Alzheimer’s growing menace. Our “Meeting of the Minds”
will be an interactive, interdisciplinary and international event at the forefront of academic,
governmental and industrial research with speakers representing a confluence of fi elds including
Stem Cell Research, Neurobiology, Artificial Intelligence, and Telemedicine.
I look forward to welcoming you next February, for a truly world-class – and unforgettable –
event.
Sincerely,
Dr. Philip Low
Founder, Chairman & CEO, NeuroVigil, Inc.
Adjunct Professor, Stanford School of Medicine
Visiting Professor, Massachusetts Institute of
Technology